R&D agreement with the Serum Institute of India for the development of conjugate vaccines

Fina will provide novel conjugation chemistry for meningitis and pneumonia conjugate vaccines.

Serum Institute of India Ltd. has established itself as the world’s largest producer of Measles and DTP group of vaccines. It is estimated that two out of every three children immunized in the world is vaccinated by a vaccine manufactured by Serum Institute.